Kamal Gandhi
Nephrology · Granada Hills, CANPI 1972510485
Payments from drug & device makers
$1,306,873in general payments, 2019–2025
Across 795 payments — averaging $1643.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Akebia Therapeutics Inc$1.1M
- Otsuka Pharmaceutical Development & Commercialization, Inc.$121K
- Gilead$82K
- GSK$19K
- Boehringer Ingelheim Pharma GmbH & Co.kg$18K
- Boehringer Ingelheim International GmbH$9K
- plus $202 from 4 others
General payments by program year
19
20
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Akebia Therapeutics Inc | 753 | $1,057,562 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $121,352 |
| Gilead | 15 | $81,920 |
| GSK | 16 | $18,688 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 2 | $18,298 |
| Boehringer Ingelheim International GmbH | 3 | $8,850 |
| Novartis | 1 | $102 |
| Boston Scientific | 1 | $64 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $15 |
How this compares
$1,306,873 in reported general payments places this provider in the 95th percentile of 1,341 nephrology providers in California.
Other nephrology in Granada Hills
- Anant DesaiGranada Hills$2.9M
- Anjay RastogiLos Angeles$6.3M
- Aamir JamalSan Dimas$5.5M
- Mohamed El-ShahawyLos Angeles$4.4M
- Kalpesh PatelCalabasas$3.6M
- Jehad HaggiagiMission Hills$3.6M
- Malvin YanSouth Gate$3.3M
- Sohan DuaNorthridge$3.2M
- Richard LafayetteStanford$3M
- Glenn ChertowStanford$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.